Search Results

Ulixertinib 50 mg  | 99.89%

TargetMol

Ulixertinib (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.

More Information Supplier Page

Ulixertinib 10 mg  | 99.89%

TargetMol

Ulixertinib (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.

More Information Supplier Page

Ulixertinib 2 mg  | 99.89%

TargetMol

Ulixertinib (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.

More Information Supplier Page

Tubercidin 25 mg  | 98.66%

TargetMol

Tubercidin, an adenosine analogue, is a nucleoside antibiotic. It is incorporated into DNA and inhibits polymerases, thereby inhibiting DNA replication and RNA and protein synthesis. This agent also exhibits antifungal and antiviral activities.

More Information Supplier Page

BI-78D3 50 mg  | 100.00%

TargetMol

BI-78D3, a competitive JNK inhibitor. IC50 of BI-78D3 is 280 nM that displays > 100 fold selectivity over p38α, and have no activity at mTOR and PI-3K.

More Information Supplier Page

BI-78D3 10 mg  | 100.00%

TargetMol

BI-78D3, a competitive JNK inhibitor. IC50 of BI-78D3 is 280 nM that displays > 100 fold selectivity over p38α, and have no activity at mTOR and PI-3K.

More Information Supplier Page

5-Iodotubercidin 50 mg  | 99.98%

TargetMol

5-Iodotubercidin is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.

More Information Supplier Page

5-Iodotubercidin 10 mg  | 99.98%

TargetMol

5-Iodotubercidin is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.

More Information Supplier Page

5-Iodotubercidin 2 mg  | 99.98%

TargetMol

5-Iodotubercidin is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.

More Information Supplier Page

VU 0357121 100 mg  | 99.99%

TargetMol

VU0357121, a positive allosteric modulator of mGlu5 (EC50: 33 nM), is inactive or very weakly antagonizing at other mGlu receptor subtypes.

More Information Supplier Page